-+ 0.00%
-+ 0.00%
-+ 0.00%

Valbiotis notifies availability of press release on REVERSE-IT study publication in Nature Communications

PUBT·07/22/2026 15:40:46
Listen to the news
Valbiotis notifies availability of press release on REVERSE-IT study publication in Nature Communications
  • Valbiotis released a press statement citing publication in Nature Communications of REVERSE-IT results for Totum•63 in prediabetes, early type 2 diabetes.
  • Randomized, placebo-controlled 24-week trial enrolled 636 participants across 52 European centers.
  • Primary endpoint met with a significant reduction in fasting blood glucose at 6 months; additional cardiometabolic measures also improved.
  • Nature Communications link: https://www.nature.com/articles/s41467-026-75626-0.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valbiotis SA published the original content used to generate this news brief via EQS News (Ref. ID: fr_reg_2370142_en) on July 22, 2026, and is solely responsible for the information contained therein.